These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27088927)

  • 1. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies.
    Sonthalia S; Daulatabad D; Sarkar R
    Indian J Dermatol Venereol Leprol; 2016; 82(3):262-72. PubMed ID: 27088927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione for skin lightening: a regnant myth or evidence-based verity?
    Sonthalia S; Jha AK; Lallas A; Jain G; Jakhar D
    Dermatol Pract Concept; 2018 Jan; 8(1):15-21. PubMed ID: 29445569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of systemic treatments for skin lightening.
    Juhasz MLW; Levin MK
    J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effect of glutathione on skin color and other related skin conditions: A systematic review.
    Dilokthornsakul W; Dhippayom T; Dilokthornsakul P
    J Cosmet Dermatol; 2019 Jun; 18(3):728-737. PubMed ID: 30895708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women.
    Handog EB; Datuin MS; Singzon IA
    Int J Dermatol; 2016 Feb; 55(2):153-7. PubMed ID: 26148180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic skin whitening/lightening agents: what is the evidence?
    Malathi M; Thappa DM
    Indian J Dermatol Venereol Leprol; 2013; 79(6):842-6. PubMed ID: 24177629
    [No Abstract]   [Full Text] [Related]  

  • 9. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topical treatment of hyperpigmentation disorders].
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S102-7. PubMed ID: 23260517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin-lightening agents: new chemical and plant extracts--ongoing search for the Holy Grail!
    Kanthraj GR
    Indian J Dermatol Venereol Leprol; 2010; 76(1):3-6. PubMed ID: 20061723
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of parenteral glutathione as a promising skin lightening agent: A controlled assessor blinded pharmacohistologic and ultrastructural study in an animal model.
    AlGhamdi KM; Kumar A; Al-Rikabi AC; Mubarak M
    Dermatol Ther; 2020 Mar; 33(2):e13211. PubMed ID: 31885127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin lightening agents - Use or abuse? - A retrospective analysis of the topical preparations used by melasma patients of darker skin types.
    Kandhari R; Khunger N
    Indian J Dermatol Venereol Leprol; 2013; 79(5):701-2. PubMed ID: 23974587
    [No Abstract]   [Full Text] [Related]  

  • 15. New and emerging treatments for hyperpigmentation.
    Alexis AF
    J Drugs Dermatol; 2014 Apr; 13(4):382-5. PubMed ID: 24719055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches.
    Gillbro JM; Olsson MJ
    Int J Cosmet Sci; 2011 Jun; 33(3):210-21. PubMed ID: 21265866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of topical and oral glutathione as a skin-whitening agent: a double-blind randomized controlled clinical trial.
    Wahab S; Anwar AI; Zainuddin AN; Hutabarat EN; Anwar AA; Kurniadi I
    Int J Dermatol; 2021 Aug; 60(8):1013-1018. PubMed ID: 33871071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.